中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2013年
36期
124-125,126
,共3页
李国栋%谢宏明%刘雯%陈梦林%谢武
李國棟%謝宏明%劉雯%陳夢林%謝武
리국동%사굉명%류문%진몽림%사무
血液透析%导管留置%透析充分性
血液透析%導管留置%透析充分性
혈액투석%도관류치%투석충분성
Hemodialysis%Catheterization%Dialysis adequacy
目的:观察长期留置中心静脉导管(TCC)在血液透析中的可行性。方法:30例无法建立血管内瘘的患者,采用Permcath双腔导管作右侧颈内静脉内置入。结果:30例均一次性置管成功,期间发生血栓形成或血流不畅2例,感染2例,出血2例,经处理后消失。除4例死亡外(非导管因素),其余均在继续透析中,血流量在200~300 mL/min之间。透析充分性与动静脉内瘘(AVF)患者比较差异无统计学意义(P>0.05)。结论:TCC长期导管安全性能高,能满足临床透析需要,为维持性透析患者建立血管通路的极好补充形式。
目的:觀察長期留置中心靜脈導管(TCC)在血液透析中的可行性。方法:30例無法建立血管內瘺的患者,採用Permcath雙腔導管作右側頸內靜脈內置入。結果:30例均一次性置管成功,期間髮生血栓形成或血流不暢2例,感染2例,齣血2例,經處理後消失。除4例死亡外(非導管因素),其餘均在繼續透析中,血流量在200~300 mL/min之間。透析充分性與動靜脈內瘺(AVF)患者比較差異無統計學意義(P>0.05)。結論:TCC長期導管安全性能高,能滿足臨床透析需要,為維持性透析患者建立血管通路的極好補充形式。
목적:관찰장기류치중심정맥도관(TCC)재혈액투석중적가행성。방법:30례무법건립혈관내루적환자,채용Permcath쌍강도관작우측경내정맥내치입。결과:30례균일차성치관성공,기간발생혈전형성혹혈류불창2례,감염2례,출혈2례,경처리후소실。제4례사망외(비도관인소),기여균재계속투석중,혈류량재200~300 mL/min지간。투석충분성여동정맥내루(AVF)환자비교차이무통계학의의(P>0.05)。결론:TCC장기도관안전성능고,능만족림상투석수요,위유지성투석환자건립혈관통로적겁호보충형식。
Objective:To observe the feasibility of the clinical application the tunneled cuffed catheter(TCC)in hemodialysis. Method:Thirty patients who cannot be established endovascular fistula were adopted in Permcath dual cavity catheter which was put in the right internal jugular vein. Result:Thirty cases were all succeeded in catheter,and thrombosis or poor blood flow occurred in 2 cases,infection in 2 cases,hemorrhaged in 2 cases, which disappeared after the treatment. Except 4 cases died(Not-TCC factors),the rest were on dialysis,whose blood flowed from 200 to 300 mL/min. There was no difference between TCC and Arteriovenous fistula(AVF)in dialysis adequacy(P>0.05). Conclusion:TCC is safe enough to meet the clinical dialysis,which is an optimal and alternative vascular access for maintenance patients in hemodialysis.